Back
Speaker illustration

undefined undefined undefined

Presentations

Prevalence of cardiac and non cardiac comorbidities in heart failure outpatients with preserved, mid ranged, and reduced ejection fraction: a single tertiary university center experience

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Access
Like
Thumbnail

Effects of ranolazine on reentrant ventricular arrhythmias induced in the late myocardial infarction period in rabbits

Event: ESC Congress 2018

Topic: Arrhythmias

Session: Electrophysiology : molecular mechanisms

Access
Like
Thumbnail

Amiodarone plus ranolazine for conversion of post-cardiac surgery atrial fibrillation: enhanced effectiveness in low versus preserved ejection fraction patients

Event: ESC Congress 2018

Topic: Rhythm Control, Antiarrhythmic Drugs

Session: Atrial fibrillation - Ablation 2

Access
Like
Thumbnail

Postoperative atrial fibrillation in patients with reduced ejection fraction heart failure undergoing cardiac surgery: ranolazine shortens time to conversion when added to amiodarone

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Drug treatment

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources